A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The norepinephrine transporter (NET) mediates reuptake of norepinephrine released from neurons, and, as such, it is an important regulator of noradrenergic neurotransmission. Recently, our laboratory reported a polymorphism in the human NET (hNET) gene A457P in an individual with the autonomic disorder orthostatic intolerance (OI). The presence of the hNET-A457P allele tracked with elevated heart rates and plasma NE levels in family members. hNET-A457P lacks >98% transport activity in several heterologous expression systems. In the present work, Western blot and biotinylation analyses performed in transiently transfected COS-7 cells revealed impairment in processing of hNET-A457P to the fully glycosylated form and a decrease in surface expression to ∼30% of hNET-wild type (hNET-wt). Because the hNET-A457P mutation is carried on a single allele in OI subjects, we examined the influence of cotransfection of hNET-wt and hNET-A457P and found that hNET-A457P exerts a dominant-negative effect on hNET-wt uptake activity. Experiments to determine oligomerization as a potential mechanism of the dominant-negative effect demonstrated that hNET-A457P coimmunoprecipitates with, and diminishes surface expression of, hNET-wt. These results reveal that hNET-A457P causes a conformational disruption that interferes with transporter biosynthetic progression and trafficking of both the mutant transporter and hNET-wt. These results elucidate a molecular mechanism for the disrupted NE homeostasis and cardiovascular function evident in OI patients with the hNET-A457P mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939 · cited 1×
“Finally, NET is a target for tricyclic antidepressants, NET-selective reuptake inhibitors and multiple psychostimulants, including amphetamine and cocaine (Ritz et al., 1990; Tatsumi et al., 1997; Sacchetti et al., 1999).”
BackgroundSelf-citationExpression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933 · cited 4×
“hNET contains three canonical N-glycosylation sites in the second extracellular loop, and immunohistochemical studies confirm a progression of hNET from light to more heavily glycosylated forms during synthesis of the mature protein (Pacholczyk et al., 1991; Melikian et al., 1994, 1996).”
BackgroundInfluentialSelf-citationOrthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594 · cited 6×
“Expression of hNET-A457P in COS-7 cells yielded transport activity at 1–2% of hNET-wt levels, consistent with our previous observations in several other cell lines (Shannon et al., 2000).”
BackgroundMethodResultInfluentialSelf-citationEsler, M., Jackman, G., Bobik, A., Leonard, P., Kelleher, D., Skews, H., Jennings, G., & Korner, P. (1981) · Hypertension · doi:10.1161/01.hyp.3.2.149 · Cited by 165
Br�ss, M., Kunz, J., Lingen, B., & B�nisch, H. (1993) · Human Genetics · doi:10.1007/bf00218272 · Cited by 127 · cited 2×
“The human NET (hNET) is a member of the Na /Cl dependent GAT (GABA transporter)/NET transporter family (Nelson, 1998; Hahn and Blakely, 2002a) and is a single-copy gene (SLC6A2) located on chromosome 16 (Brüss et al., 1993).”
BackgroundJacob, G., Shannon, J. R., Costa, F., Furlan, R., Biaggioni, I., Mosqueda-Garcia, R., Robertson, R. M., & Robertson, D. (1999) · Circulation · doi:10.1161/01.cir.99.13.1706 · Cited by 117 · cited 1×
“The proband and family members carrying the heterozygous mutation also exhibited evidence of NET dysfunction (Jacob et al., 1999; Shannon et al., 2000).”
BackgroundSelf-citation
Research works printed but not linked: 58
- 10.1124/mol.59.3.514 · DOI
- 1998, J Pharmacol Exp Ther, 287, 733, 10.1016/S0022-3565(24)37851-6 · DOI · Paper page
- 1998, J Pharmacol Exp Ther, 287, 744, 10.1016/S0022-3565(24)37852-8 · DOI · Paper page
- 10.1006/jmcc.2000.1319 · DOI
- 10.1523/JNEUROSCI.19-12-04705.1999 · DOI · Paper page
- 10.1016/S0003-9861(02)00232-1 · DOI
- 2001, J Neurosci, 21, 8319, 10.1523/JNEUROSCI.21-21-08319.2001 · DOI · Paper page
- 10.1016/0735-1097(94)00353-R · DOI · Paper page
- 1998, Hypertension, 32, 831, 10.1161/01.HYP.32.5.831 · DOI
- 1993, Hum Genet, 91, 278
- 1995, Mol Pharmacol, 48, 1030, 10.1016/S0026-895X(25)10570-1 · doi:10.1016/s0026-895x(25)10570-1
- 10.1523/JNEUROSCI.18-19-07739.1998 · DOI
- 10.1006/bbrc.1998.9158 · doi:10.1006/bbrc.1998.9158
- 10.1074/jbc.272.45.28321 · DOI · Paper page
- 1999, J Pharmacol Exp Ther, 289, 877, 10.1016/S0022-3565(24)38214-X · DOI · Paper page
- 10.1073/pnas.97.15.8641 · DOI · Paper page
- 1983, Physiol Rev, 63, 845
- 10.1111/j.1469-7793.2001.0479c.xd · DOI
- 1995, J Exp Biol, 198, 2197, 10.1242/jeb.198.10.2197 · DOI · Paper page
- 1994, J Biol Chem, 269, 15985, 10.1016/S0021-9258(17)33961-3 · DOI · Paper page
- 10.1074/jbc.274.33.23020 · doi:10.1074/jbc.274.33.23020
- 1994, J Biol Chem, 269, 7124, 10.1016/S0021-9258(17)37256-3 · DOI · Paper page
- Hahn MK, Blakely RD ( 2002a) Gene organization and polymorphisms of monoamine transporters. relationship to psychiatric and other complex diseases. In: Neurotransmitter transporters. Structure, function, and regulation (Reith MEA, ed), pp 111–169. Totowa, NJ: Humana. · DOI
- 10.1038/sj.tpj.6500106 · DOI
- 10.1073/pnas.181344298 · DOI · Paper page
- 1961, Br J Pharmacol, 21, 523
- 10.1021/bi00096a030 · DOI
- 10.1073/pnas.060408997 · DOI · Paper page
- 10.1074/jbc.274.16.10731 · DOI
- 10.1038/227680a0 · DOI · Paper page
- 1997, J Psychopharmacol, 11, S39
- 10.1523/JNEUROSCI.14-08-04903.1994 · DOI · Paper page
- 10.1016/S0896-6273(00)00012-X · DOI · Paper page
- 1994, J Biol Chem, 269, 12290, 10.1016/S0021-9258(17)32714-X · DOI · Paper page
- 1996, Mol Pharmacol, 50, 266, 10.1016/S0026-895X(25)09218-1 · DOI · Paper page
- 1992, J Cardiovasc Pharmacol, 19, 10, 10.1097/00005344-199201000-00002 · DOI
- 10.1046/j.1471-4159.1994.63030917.x · DOI
- 10.1172/JCI8688 · DOI · Paper page
- 10.1097/00008571-200203000-00010 · DOI
- 10.1074/jbc.M110783200 · DOI
- 10.1016/0024-3205(90)90132-B · DOI · Paper page
- 10.1038/sj.bjp.0702926 · DOI · Paper page
- 10.1176/appi.ajp.122.5.509 · doi:10.1176/appi.ajp.122.5.509
- 10.1074/jbc.M007357200 · DOI · Paper page
- 10.2337/diab.45.6.801 · DOI · Paper page
- 10.1074/jbc.M205602200 · DOI · Paper page
- 10.1161/01.RES.55.5.689 · DOI · Paper page
- 1989, Naunyn Schmiedebergs Arch Pharmacol, 340, 502
- 10.1093/eurheartj/12.suppl_F.38 · DOI
- 10.1006/mcne.1997.0619 · DOI
- 10.1002/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3 · DOI · Paper page
- 10.1074/jbc.274.51.36058 · DOI
- 10.1523/JNEUROSCI.23-05-01697.2003 · DOI · Paper page
- 1992, J Pharmacol Exp Ther, 260, 427, 10.1016/S0022-3565(25)11249-4 · DOI · Paper page
- 10.1074/jbc.M201926200 · DOI · Paper page
- 1978, Eur J Pharmacol, 51, 193, 10.1016/0014-2999(78)90404-1 · doi:10.1016/0014-2999(78)90404-1
- 10.1038/74839 · DOI · Paper page
- 10.1074/jbc.274.44.31123 · DOI · Paper page
Cited by
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics
Murphy, D. L. (2004) · Molecular Interventions · doi:10.1124/mi.4.2.8 · Cited by 448
Neurotransmitter transporters: molecular function of important drug targets
GETHER, U., ANDERSEN, P., LARSSON, O., & SCHOUSBOE, A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.003 · Cited by 309
A Mutant of the Arabidopsis Phosphate Transporter PHT1;1 Displays Enhanced Arsenic Accumulation
Catarecha, P., Segura, M. D., Franco-Zorrilla, J. M., García-Ponce, B., Lanza, M., Solano, R., Paz-Ares, J., & Leyva, A. (2007) · The Plant Cell · doi:10.1105/tpc.106.041871 · Cited by 303
The solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 269
Metadata
- Authors
- Hahn, M. K., Robertson, D., & Blakely, R. D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-06-01
- Volume
- 23
- Issue
- 11
- Pages
- 4470-4478
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 107
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.